Profile
Julian Aleksov is the founder of Vivesto AB, which was founded in 1988.
He is currently the Chairman of Qdoxx Pharma AB, GlucoGene Pharma AB, Alzinova AB (founded in 2023), Oasmia Global Supplies AB, Oasmia Animal Health AB, and Managing Director of Oasmia SA. Additionally, he holds the position of Director & Partner at Alceco International S.A. since 2000 and Director at Maida Vale Capital AB and Hunterhex AB.
Julian Aleksov active positions
| Companies | Position | Start |
|---|---|---|
| ALZINOVA AB | Chairman | 2022-12-31 |
Oasmia SA | Chief Executive Officer | 2010-07-01 |
Qdoxx Pharma AB | Chairman | 2010-07-01 |
GlucoGene Pharma AB | Chairman | 2010-07-01 |
Oasmia Global Supplies AB | Chairman | - |
Oasmia Animal Health AB | Chairman | - |
Alceco International S.A. | Director/Board Member | 1999-12-31 |
Maida Vale Capital AB
Maida Vale Capital AB Investment Banks/BrokersFinance Provides securities brokerage services | Director/Board Member | - |
Hunterhex AB | Director/Board Member | - |
Former positions of Julian Aleksov
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Vivesto AB
Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Oasmia SA | |
Qdoxx Pharma AB | |
GlucoGene Pharma AB | |
Alceco International S.A. | |
Alzinova AB
Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Oasmia Global Supplies AB | |
Oasmia Animal Health AB | |
Maida Vale Capital AB
Maida Vale Capital AB Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Hunterhex AB |
- Stock Market
- Insiders
- Julian Aleksov
















